Profile
Ascend is a venture capital firm based in Seattle, focusing on pre-seed investments. It was founded by a team with a keen interest in supporting startups, particularly those emerging from the rich talent pool of Seattle, where one in four AI engineers in the United States resides. The firm stands out due to its active engagement with early-stage tech ventures in the Pacific Northwest and its commitment to backing innovative solutions driven by cutting-edge technology.
Ascend invests primarily in AI-driven startups with interests spanning across multiple sectors, including HealthTech, Internet and Web Services, and Generative AI platforms. The firm offers investment support to ventures at pre-seed stages, predominantly focusing on the North American tech landscape. It manages funds targeting early-stage venture investments and leverages its local expertise to nurture pioneering projects through the initial stages of development.
Notable investments by Ascend include Adyn, a company setting new standards for birth control; Aerolane, specializing in cost-effective air services; Athanor AI, focusing on hardware and software verification; Atypical AI, which offers comprehensive AI tools for education; and AZX, delivering AI solutions for infrastructure industries.
Industry
Ascend Funds
| Name | Type |
|
|
|
Size | AUM | Launch date |
|---|---|---|---|---|---|---|---|
|
Ascend Venture Capital I
|
Venture Capital (VC)
|
SaaS
Software
AI
Machine Learning (ML)
|
Pre-seed
Seed
|
North America
|
$5-10 m
|
$140 M
|
August 2019
|
Contacts
Instant access on the web. Plans from $129/month — see pricing.